Tekla Capital Management LLC reduced its holdings in shares of Teligent Inc (NASDAQ:TLGT) by 88.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 101,458 shares of the company’s stock after selling 804,904 shares during the quarter. Tekla Capital Management LLC owned approximately 0.19% of Teligent worth $401,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Bridgeway Capital Management Inc. raised its position in Teligent by 112.7% during the third quarter. Bridgeway Capital Management Inc. now owns 283,081 shares of the company’s stock valued at $1,118,000 after acquiring an additional 150,000 shares in the last quarter. Virtu Financial LLC bought a new position in Teligent during the third quarter valued at approximately $172,000. BlackRock Inc. raised its position in Teligent by 0.5% during the third quarter. BlackRock Inc. now owns 3,463,605 shares of the company’s stock valued at $13,681,000 after acquiring an additional 16,198 shares in the last quarter. Wells Fargo & Company MN raised its position in Teligent by 15.9% during the third quarter. Wells Fargo & Company MN now owns 123,329 shares of the company’s stock valued at $488,000 after acquiring an additional 16,919 shares in the last quarter. Finally, Northpointe Capital LLC bought a new position in Teligent during the third quarter valued at approximately $2,948,000. Institutional investors and hedge funds own 68.05% of the company’s stock.

Shares of TLGT stock opened at $1.86 on Wednesday. Teligent Inc has a 12 month low of $1.85 and a 12 month high of $4.52. The company has a debt-to-equity ratio of 3.31, a quick ratio of 1.79 and a current ratio of 2.77. The company has a market cap of $110.29 million, a price-to-earnings ratio of -9.79 and a beta of 0.94.

Teligent (NASDAQ:TLGT) last announced its quarterly earnings results on Tuesday, November 13th. The company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01). Teligent had a negative return on equity of 43.00% and a negative net margin of 54.17%. The company had revenue of $18.29 million for the quarter, compared to the consensus estimate of $19.80 million. On average, sell-side analysts anticipate that Teligent Inc will post -0.16 earnings per share for the current fiscal year.

TLGT has been the topic of several analyst reports. Canaccord Genuity set a $4.00 price target on Teligent and gave the company a “hold” rating in a report on Monday, August 13th. ValuEngine upgraded Teligent from a “hold” rating to a “buy” rating in a report on Friday, August 10th.

TRADEMARK VIOLATION WARNING: “Teligent Inc (TLGT) Position Reduced by Tekla Capital Management LLC” was published by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://www.watchlistnews.com/teligent-inc-tlgt-position-reduced-by-tekla-capital-management-llc/2662882.html.

Teligent Profile

Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.

See Also: What is an Initial Public Offering (IPO)?

Want to see what other hedge funds are holding TLGT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teligent Inc (NASDAQ:TLGT).

Institutional Ownership by Quarter for Teligent (NASDAQ:TLGT)

Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.